U.S. Logistics Stock News

The market is giving H&R Block a polite golf clap, not a standing ovation. The stock is up just over 1% after earnings, even though this tax season delivered US$5.31 in adjusted earnings per share and free cash flow of US$756 million on US$3.95b of revenue. That is a powerful cash engine for a company often treated as a sleepy tax preparer. Coming into the print, H&R Block had already climbed over the past month, so expectations were not low. The focus now is on whether this level of...

Tapestry (TPR) is back in focus after reporting fourth quarter and full year 2026 results that showed higher sales, a move from loss to profit, and updates on dividends and buybacks. See our latest analysis for Tapestry. The immediate reaction to Tapestry’s earnings, dividend increase and buyback update has been sharp, with the share price down 20.56% over the past week and 8.82% over the past month, even though the 1 year total shareholder return of 29.68% and very large 3 year and 5 year...

Nam Tai Property entered this earnings season with the stock stuck at US$4.40 and no immediate price reaction after the Q2 release. That flat line hides a tougher story. Quarterly revenue sat at US$4.95m while the company booked a net loss from continuing operations of US$2.92m. For a stock that already declined over the past three months, this fresh hit to profitability is the headline. The market’s calm looks less like confidence and more like a pause while investors reassess how much...

Zeta Global Holdings (ZETA) reported second quarter 2026 results that showed sales of US$442.77 million and a return to profitability, and then raised both third quarter and full year 2026 revenue and earnings guidance. See our latest analysis for Zeta Global Holdings. Against this backdrop, Zeta Global Holdings has seen strong momentum, with a 51.38% 90 day share price return and a 394.89% 5 year total shareholder return, as recent earnings and leadership updates help shape how investors...

Pfizer stock has returned roughly 28.4% less over the past five years, yet the current valuation screens as somewhat expensive on market multiples and only mixed on the broader checks. That combination leaves investors weighing whether the recent recovery in the share price is already pricing in much of the good news from the company’s pipeline and product portfolio. Pfizer’s share price is down about 28.4% over five years, which suggests long term holders have experienced a material drag on...

Patriot National Bancorp stock barely budged into the weekend, slipping just 0.9% to about US$1.10, even though the quarterly story quietly flipped from red to black. After a year of losses, the bank posted a small profit in Q2 2026, with basic earnings per share just above zero and net income modestly in the black. For a lender that has carried elevated non performing loans and a rich price to book ratio, the key question now is whether this early profit flicker can hold over the next...

Digimarc stock bounced 7% to US$7.53 into the earnings aftermath, a sharp move for a company that is still working through shrinking recurring software revenue and sizable losses. The headline this quarter is a squeeze on the profit engine. Quarterly revenue sat at US$7.4m while the net loss from ongoing operations reached US$12.1m, and annual recurring revenue fell to US$11.6m. For traders focused on today, that jump can look encouraging. For long term investors, the key question is whether...

Sigma Lithium stock climbed 5.8% to US$11.99 over the past session, even though the headline number was a swing back into a small loss for the quarter. The market clearly latched onto one thing: record quarterly revenue of about US$55 million and a reported gross margin near 60% with an earnings before interest, tax, depreciation and amortization margin of 47% for a lithium producer that was loss making over the last twelve months. Today was not about accounting profit. It was about whether...

National Presto Industries entered this earnings season with a reputation as a steady defense and consumer products hybrid trading on a modest 23.3x trailing P/E. The stock barely flinched after the report, rising about 1.5%, yet the headline result was far from sleepy. Second quarter basic EPS landed at US$2.21 on revenue of US$146.6m, helping lift trailing 12 month earnings to US$5.98 per share. The core story this quarter is about profit quality. Net income from continuing operations over...

VSE Corporation recently reported second-quarter 2026 results, with revenue rising to US$449.14 million and net income to US$28.52 million, and its board declared a regular US$0.10 per-share quarterly dividend payable on October 29, 2026 to shareholders of record on October 15. Management also raised full-year 2026 revenue growth guidance to a range of 61% to 64%, reflecting increased confidence after stronger-than-expected earnings and progress integrating recent aviation aftermarket...

SoundHound AI (SOUN) has drawn fresh attention after reporting second quarter 2026 results and updating its full year outlook. The company paired higher sales with a narrower quarterly loss, while lifting revenue guidance. See our latest analysis for SoundHound AI. SoundHound AI’s latest earnings and raised guidance arrive after a mixed year for investors, with the share price down 29.91% year to date and the 1 year total shareholder return declining 52.34%, although the 3 year total...

Smith-Midland stock inched up 1.7% into the weekend, a modest move for a precast concrete specialist that just put conflicting signals on the table. The headline is a squeeze on profitability. Quarterly basic earnings per share sit at US$0.26 on revenue of US$23.4m, while trailing net margin has eased to 8.6% compared with 13.2% a year earlier. The market is treating this as a routine quarter. The numbers suggest investors are still weighing pressure on margins against a share price that...

AI excitement on Wall Street is not just about chip stocks. If trading volumes and investor interest stay elevated, the companies that run US market infrastructure, clearing, and trading venues sit close to the action. For investors who do not want to ignore that link, this creates a timely story. This article walks through three stocks that appear well placed to benefit from the current news driven setup. The stocks covered below are just a sample, and the full screen surfaced 30 more US...

Digi Power X stock closed at US$3.97 on Friday, down about 4% on the day and sitting on a 90 day slide of roughly 45%. The market is reacting to another quarter of losses, with Q2 2026 revenue at US$6.6m against a net loss of US$14.4m. The bigger story for long term investors is not this quarter’s loss. It is the tension between very high revenue growth forecasts and a balance sheet that has relied heavily on fresh equity and now needs debt financing and asset deals to support an ambitious...

Wendy's stock has fallen sharply over the past five years, yet both a Discounted Cash Flow (DCF) intrinsic value estimate and earnings-based multiples currently point to the shares trading at a discount to what the business may be worth. The recent rebound in the share price after talk of a potential take-private bid has pulled attention back to whether that discount still offers enough compensation for the risks around the turnaround. Wendy's shareholders have seen the stock decline 53.9%...

Coherent stock barely moved after earnings, slipping about 0.4% to roughly US$325 even though the company just closed out a record year in its core optical and data center business. The headline is simple: this was a profitability and margin story, not a trading day story. Quarterly revenue reached about US$2.0b in Q4 with basic earnings per share of about US$1.23, capping roughly US$7.1b of sales and solid earnings over the past year. With the share price already carrying a rich trailing...

Lemonade conference appearance draws fresh focus to growth and losses Lemonade (LMND) heads into its Oppenheimer Technology, Internet & Communications Conference appearance on 12 August, with investors weighing strong AI driven revenue momentum against continued net losses and a recent pullback in the stock. See our latest analysis for Lemonade. Lemonade’s share price has declined 21.6% over the past 30 days and is down 30.7% year to date, yet the 3 year total shareholder return of about 2.8x...

Bally’s entered this earnings report positioned as a beaten-up value story, yet the stock rose 3.7% to US$13.99 after the release. That move came even as the company reported another sizable quarterly loss, with basic earnings per share at a loss of US$2.41 and net income excluding extra items at a loss of US$146.1 million on US$792.2 million of revenue in Q2 2026. The market’s early response suggests investors are focusing less on current losses and more on what this revenue base and low...

Nektar Therapeutics came into this earnings print trading like a high expectation growth story, with the stock up over the past month, only to see the shares slip about 4% on the immediate reaction. The tension is simple. Investors are paying a rich revenue multiple for a company that still reports modest revenue of just over US$10 million and a quarterly net loss above US$40 million. The real headline is not the loss itself. It is the size of that loss against an already expensive P/S...

BigBear.ai Holdings (BBAI) is back in focus after announcing a $100 million follow-on equity offering, paired with more than 20 new contract wins and an expanded secure generative AI platform for defense clients. See our latest analysis for BigBear.ai Holdings. The recent equity raise and contract wins come after a mixed period for BigBear.ai Holdings, with the share price rising about 15% over the past month but falling around 44% year to date. The 3 year total shareholder return remains...

The market gave NexPoint Diversified Real Estate Trust a muted nod, with the stock up about 1% to US$5.11, yet the earnings story is far more emotional than that small move suggests. After a long stretch of heavy losses, the headline this quarter is simple. Funds From Operations, the core profit yardstick for a real estate trust, swung back into positive territory at US$3.4m, or US$0.07 per share. Net income barely broke even. The real question for you now is whether this first clear step...

Pediatrix Medical Group, Inc. recently reported past second-quarter 2026 results, with sales of US$487.78 million and net income of US$39.84 million, alongside higher earnings per share from continuing operations compared with a year earlier. At the same time, the company completed a meaningful share repurchase effort, retiring millions of shares across long-running buyback programs, which can meaningfully affect per-share financial metrics and capital allocation priorities. With this...

ASP Isotopes stock barely flinched after earnings, slipping only 0.2% to about US$4.27, yet the story behind the print is far more charged than the price move suggests. Quarterly revenue sits at US$5.1 million while the company continues to post deep net losses over the last twelve months. The real tension for you as a shareholder is not today’s tiny tick in the quote. It is whether this high P/S multiple and ongoing dilution can be justified by the revenue growth that analysts are modeling...

QXO stock slipped 2.6% to US$14.51 into the weekend, capping a choppy week, yet the headline from Q2 is not the share price. The company delivered another loss, with basic earnings per share at US$0.14 in the red and net income excluding extra items also in the red at US$109 million. The real story for long term holders is the tension between those ongoing losses and a valuation framework that points to much higher long run potential. The rest of this report breaks down how that gap might...